These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25818176)

  • 1. Visual impairment in an optineurin mouse model of primary open-angle glaucoma.
    Tseng HC; Riday TT; McKee C; Braine CE; Bomze H; Barak I; Marean-Reardon C; John SW; Philpot BD; Ehlers MD
    Neurobiol Aging; 2015 Jun; 36(6):2201-12. PubMed ID: 25818176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice.
    Chi ZL; Akahori M; Obazawa M; Minami M; Noda T; Nakaya N; Tomarev S; Kawase K; Yamamoto T; Noda S; Sasaoka M; Shimazaki A; Takada Y; Iwata T
    Hum Mol Genet; 2010 Jul; 19(13):2606-15. PubMed ID: 20388642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of optineurin siRNA on apoptotic genes and apoptosis in RGC-5 cells.
    Li H; Ao X; Jia J; Wang Q; Zhang Z
    Mol Vis; 2011; 17():3314-25. PubMed ID: 22194658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related visual impairments and retinal ganglion cells axonal degeneration in a mouse model harboring OPTN (E50K) mutation.
    Hou M; Shao Z; Zhang S; Liu X; Fan P; Jiang M; Zhao Y; Xiao R; Yuan H
    Cell Death Dis; 2022 Apr; 13(4):362. PubMed ID: 35436991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced optineurin E50K-TBK1 interaction evokes protein insolubility and initiates familial primary open-angle glaucoma.
    Minegishi Y; Iejima D; Kobayashi H; Chi ZL; Kawase K; Yamamoto T; Seki T; Yuasa S; Fukuda K; Iwata T
    Hum Mol Genet; 2013 Sep; 22(17):3559-67. PubMed ID: 23669351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optineurin in primary open angle glaucoma.
    Sarfarazi M; Rezaie T
    Ophthalmol Clin North Am; 2003 Dec; 16(4):529-41. PubMed ID: 14740994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mice expressing the Tyr437His mutant of human myocilin protein develop glaucoma.
    Zhou Y; Grinchuk O; Tomarev SI
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1932-9. PubMed ID: 18436825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated myocilin and heterozygous Sod2 deficiency act synergistically in a mouse model of open-angle glaucoma.
    Joe MK; Nakaya N; Abu-Asab M; Tomarev SI
    Hum Mol Genet; 2015 Jun; 24(12):3322-34. PubMed ID: 25740847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygote Wdr36-deficient mice do not develop glaucoma.
    Gallenberger M; Kroeber M; März L; Koch M; Fuchshofer R; Braunger BM; Iwata T; Tamm ER
    Exp Eye Res; 2014 Nov; 128():83-91. PubMed ID: 25261604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal Ganglion Cells With a Glaucoma OPTN(E50K) Mutation Exhibit Neurodegenerative Phenotypes when Derived from Three-Dimensional Retinal Organoids.
    VanderWall KB; Huang KC; Pan Y; Lavekar SS; Fligor CM; Allsop AR; Lentsch KA; Dang P; Zhang C; Tseng HC; Cummins TR; Meyer JS
    Stem Cell Reports; 2020 Jul; 15(1):52-66. PubMed ID: 32531194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A glaucoma-associated mutant of optineurin selectively induces death of retinal ganglion cells which is inhibited by antioxidants.
    Chalasani ML; Radha V; Gupta V; Agarwal N; Balasubramanian D; Swarup G
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1607-14. PubMed ID: 17389490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of protein trafficking upon overexpression and mutation of optineurin.
    Park B; Ying H; Shen X; Park JS; Qiu Y; Shyam R; Yue BY
    PLoS One; 2010 Jul; 5(7):e11547. PubMed ID: 20634958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray expression profile analysis of long non-coding RNAs in optineurin E50K mutant transgenic mice.
    Li Y; Jin L; Dong A; Zhou X; Yuan H
    Mol Med Rep; 2017 Aug; 16(2):1255-1261. PubMed ID: 29067446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mouse retinal ganglion cell axons and soma from glaucomatous and ischemic injury by cytoplasmic overexpression of Nmnat1.
    Zhu Y; Zhang L; Sasaki Y; Milbrandt J; Gidday JM
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):25-36. PubMed ID: 23211826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
    Chintala SK
    Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant WDR36 directly affects axon growth of retinal ganglion cells leading to progressive retinal degeneration in mice.
    Chi ZL; Yasumoto F; Sergeev Y; Minami M; Obazawa M; Kimura I; Takada Y; Iwata T
    Hum Mol Genet; 2010 Oct; 19(19):3806-15. PubMed ID: 20631153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of mutated mouse myocilin induces open-angle glaucoma in transgenic mice.
    Senatorov V; Malyukova I; Fariss R; Wawrousek EF; Swaminathan S; Sharan SK; Tomarev S
    J Neurosci; 2006 Nov; 26(46):11903-14. PubMed ID: 17108164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant human myocilin induces strain specific differences in ocular hypertension and optic nerve damage in mice.
    McDowell CM; Luan T; Zhang Z; Putliwala T; Wordinger RJ; Millar JC; John SW; Pang IH; Clark AF
    Exp Eye Res; 2012 Jul; 100():65-72. PubMed ID: 22575566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescue of retinal function by BDNF in a mouse model of glaucoma.
    Domenici L; Origlia N; Falsini B; Cerri E; Barloscio D; Fabiani C; Sansò M; Giovannini L
    PLoS One; 2014; 9(12):e115579. PubMed ID: 25536045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and course of patients with glaucoma with the E50K mutation in the optineurin gene.
    Aung T; Rezaie T; Okada K; Viswanathan AC; Child AH; Brice G; Bhattacharya SS; Lehmann OJ; Sarfarazi M; Hitchings RA
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2816-22. PubMed ID: 16043855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.